174 related articles for article (PubMed ID: 33749551)
1. Therapeutic Potential of Natural Compounds in Lung Cancer.
Al-Yozbaki M; Wilkin PJ; Gupta GK; Wilson CM
Curr Med Chem; 2021; 28(39):7988-8002. PubMed ID: 33749551
[TBL] [Abstract][Full Text] [Related]
2. Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action.
Aung TN; Qu Z; Kortschak RD; Adelson DL
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28304343
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of natural compounds in cell death induction and sensitization to chemotherapeutic drugs in lung cancer.
Wattanathamsan O; Hayakawa Y; Pongrakhananon V
Phytother Res; 2019 Oct; 33(10):2531-2547. PubMed ID: 31293008
[TBL] [Abstract][Full Text] [Related]
4. Quinonoids: Therapeutic Potential for Lung Cancer Treatment.
Ying HZ; Yu CH; Chen HK; Zhang HH; Fang J; Wu F; Yu WY
Biomed Res Int; 2020; 2020():2460565. PubMed ID: 32337232
[TBL] [Abstract][Full Text] [Related]
5. Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway.
Wei C; Yao X; Jiang Z; Wang Y; Zhang D; Chen X; Fan X; Xie C; Cheng J; Fu J; Leung EL
Pharmacol Res; 2019 Jun; 144():79-89. PubMed ID: 30974169
[TBL] [Abstract][Full Text] [Related]
6. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models.
Martínez-García D; Pérez-Hernández M; Korrodi-Gregório L; Quesada R; Ramos R; Baixeras N; Pérez-Tomás R; Soto-Cerrato V
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31412593
[TBL] [Abstract][Full Text] [Related]
7. Molecular Studies on Novel Antitumor Bis 1,4-Dihydropyridine Derivatives Against Lung Carcinoma and their Limited Side Effects on Normal Melanocytes.
Mohamed MF; Ibrahim NS; Elwahy AHM; Abdelhamid IA
Anticancer Agents Med Chem; 2018; 18(15):2156-2168. PubMed ID: 30338746
[TBL] [Abstract][Full Text] [Related]
8. The Chromone Alkaloid, Rohitukine, Affords Anti-Cancer Activity via Modulating Apoptosis Pathways in A549 Cell Line and Yeast Mitogen Activated Protein Kinase (MAPK) Pathway.
Safia ; Kamil M; Jadiya P; Sheikh S; Haque E; Nazir A; Lakshmi V; Mir SS
PLoS One; 2015; 10(9):e0137991. PubMed ID: 26405812
[TBL] [Abstract][Full Text] [Related]
9. Individual dose and scheduling determine the efficacy of combining cytotoxic anticancer agents with a kinase inhibitor in non-small-cell lung cancer.
Meiler J; Guyot M; Hoffarth S; Wesarg E; Höhn Y; Breitenbuecher F; Schuler M
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1385-94. PubMed ID: 22488173
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
11. A Quinone-Containing Compound Enhances Camptothecin-Induced Apoptosis of Lung Cancer Through Modulating Endogenous ROS and ERK Signaling.
Chou HL; Fong Y; Wei CK; Tsai EM; Chen JY; Chang WT; Wu CY; Huang HW; Chiu CC
Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):241-252. PubMed ID: 27677293
[TBL] [Abstract][Full Text] [Related]
12. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
13. Targeting cellular microtubule by phytochemical apocynin exhibits autophagy-mediated apoptosis to inhibit lung carcinoma progression and tumorigenesis.
Paul S; Chakrabarty S; Ghosh S; Nag D; Das A; Dastidar DG; Dasgupta M; Dutta N; Kumari M; Pal M; Chakrabarti G
Phytomedicine; 2020 Feb; 67():153152. PubMed ID: 31887479
[TBL] [Abstract][Full Text] [Related]
14. Novel agents in the management of lung cancer.
Kennedy B; Gargoum F; Bystricky B; Curran DR; O'Connor TM
Curr Med Chem; 2010; 17(35):4291-325. PubMed ID: 20939812
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma.
Hastings JF; Gonzalez Rajal A; Latham SL; Han JZ; McCloy RA; O'Donnell YE; Phimmachanh M; Murphy AD; Nagrial A; Daneshvar D; Chin V; Watkins DN; Burgess A; Croucher DR
Elife; 2020 Jun; 9():. PubMed ID: 32513387
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of antitumor activity of taxanes in lung cancer (Review).
Zhao J; Kim JE; Reed E; Li QQ
Int J Oncol; 2005 Jul; 27(1):247-56. PubMed ID: 15942666
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549.
Marostica LL; Silva IT; Kratz JM; Persich L; Geller FC; Lang KL; Caro MS; Durán FJ; Schenkel EP; Simões CM
Chem Res Toxicol; 2015 Oct; 28(10):1949-60. PubMed ID: 26372186
[TBL] [Abstract][Full Text] [Related]
19. The potential of retinoids for combination therapy of lung cancer: Updates and future directions.
Tripathi SK; Pandey K; Panda M; Spinella MJ; Rengasamy KR; Biswal BK
Pharmacol Res; 2019 Sep; 147():104331. PubMed ID: 31254665
[TBL] [Abstract][Full Text] [Related]
20. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
